NCT04853784 (STARS-CC01) is a clinical trial of intracorporeal anastomosis in Colon Cancer, sponsored by The First Hospital of Jilin University.

Who is sponsoring NCT04853784?

NCT04853784 is sponsored by The First Hospital of Jilin University.

What drugs are being tested in NCT04853784?

Interventions in NCT04853784: intracorporeal anastomosis.

What condition does NCT04853784 study?

NCT04853784 studies Colon Cancer, Surgery, Totally Laparoscopic, Intracorporeal Anastomosis.

Is NCT04853784 still recruiting?

NCT04853784 is currently status unknown. Last updated 21 April 2021.

Last reviewed 2021-04-21 · How we verify

NCT04853784: STARS-CC01

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Registration Study of Totally Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery

Status unknown Last updated 21 April 2021

What this trial tests

trial testing intracorporeal anastomosis in Colon Cancer in 650 participants. Status unknown.

Timeline

1 May 2021

Primary endpoint
1 May 2023

30 May 2023

Quick facts

Lead sponsor	The First Hospital of Jilin University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	650
Start date	1 May 2021
Primary completion	1 May 2023
Estimated completion	30 May 2023
Sites	1 location across China

Drugs / interventions tested

intracorporeal anastomosis

Conditions studied

Colon Cancer — all drugs for Colon Cancer →
Surgery — all drugs for Surgery →
Totally Laparoscopic — all drugs for Totally Laparoscopic →
Intracorporeal Anastomosis — all drugs for Intracorporeal Anastomosis →

Sponsor

The First Hospital of Jilin University

Who can join

Adults 18 to 80, any sex, with Colon Cancer or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a comparison of totally laparoscopic and laparoscopic-assisted colon cancer resection, a prospective registration study comparing the safety and benefits of the two operations

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Precision oncology in gynecologic cancers: molecular taxonomy, biomarker-guided therapeutics, and the challenge of therapeutic resistance.
Waseem S, Zhan J, Xiao X, Bai P. · · 2026 · PMID 42022325 · DOI 10.3389/fonc.2026.1785469

Verify or expand the search:

Other recruiting trials for Colon Cancer

Currently open trials in the same condition.

NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting

Other The First Hospital of Jilin University trials

Trials by the same sponsor.

NCT07308340 — Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT · not yet recruiting
NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres · NA · recruiting
NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients · not yet recruiting
NCT07440368 — Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness · not yet recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04853784 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Jilin University
Last refreshed: 21 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04853784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing